ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Scutellaria Baicalensis Extract

Also known as: Scutellaria baicalensis Georgi, Chinese skullcap, Baikal skullcap, Scutellaria baicalensis

Overview

Scutellaria baicalensis, commonly known as Chinese skullcap or Baikal skullcap, is a traditional medicinal herb native to East Asia, widely utilized in Traditional Chinese Medicine. Its extract is rich in bioactive flavonoids, primarily baicalin, baicalein, and wogonin, which are believed to be responsible for its diverse pharmacological activities. The supplement is primarily investigated for its anti-inflammatory, antioxidant, neuroprotective, and anticancer properties. While extensive preclinical research, including numerous animal and cell studies, supports these potential benefits, high-quality human randomized controlled trials (RCTs) are still limited. Systematic reviews and meta-analyses predominantly focus on preclinical models, with clinical evidence awaiting further confirmation. It is available as an herbal extract and botanical supplement.

Benefits

Scutellaria baicalensis extract demonstrates several promising benefits, primarily supported by preclinical research: - **Antidepressant Effects:** A 2024 systematic review and meta-analysis of 13 preclinical animal studies (n=270 animals) indicated that *S. baicalensis* significantly improved depressive-like behaviors across various models. The effects were linked to the modulation of inflammatory, oxidative stress, apoptotic pathways, and neurotransmitter systems (e.g., TrkB-BDNF, PI3K-AKT, MAPK, NF-κB). This suggests strong potential, though human efficacy needs confirmation. - **Anticancer Activity:** Another 2024 meta-analysis of 12 preclinical studies on hepatocellular carcinoma (HCC) models showed that *S. baicalensis* and its flavonoids significantly reduced tumor weight and induced cell cycle arrest and inhibited proliferation in liver cancer cells. The statistical significance was very strong (p < 0.00001), indicating robust preclinical evidence for its anticancer potential. - **Anti-inflammatory and Analgesic Effects:** Animal studies suggest that *S. baicalensis* extract can alleviate pain and inflammation, likely by suppressing reactive oxygen species and modulating lipid metabolism. While promising, these findings require further clinical validation. - **Other Potential Benefits:** Systematic reviews highlight the therapeutic potential of baicalin and baicalein in breast cancer and other inflammatory conditions. However, clinical data supporting these applications are currently sparse, emphasizing the need for more human trials.

How it works

The primary bioactive flavonoids in *Scutellaria baicalensis*, including baicalin, baicalein, and wogonin, exert their effects through multiple molecular pathways. They act as potent anti-inflammatory agents by inhibiting NF-κB signaling, thereby reducing the production of pro-inflammatory cytokines. As antioxidants, they scavenge reactive oxygen species (ROS), mitigating oxidative stress. For neuroprotection, they modulate BDNF-TrkB signaling and neurotransmitter systems, which supports neuronal survival and function. In the context of anticancer activity, these compounds induce cell cycle arrest and apoptosis in tumor cells by modulating cyclin proteins and activating apoptotic pathways. While these flavonoids undergo metabolism, their moderate bioavailability allows for relevant tissue distribution.

Side effects

Overall, *Scutellaria baicalensis* extract is considered to have a low toxicity profile in preclinical models. However, comprehensive data on common side effects in humans are limited due to the scarcity of large-scale clinical trials. Mild gastrointestinal discomfort is a potential, though not well-documented, side effect. No major drug interactions or contraindications have been firmly established. Nevertheless, caution is advised when co-administering *S. baicalensis* with anticoagulant medications, as the flavonoids present in the extract may possess blood-thinning properties, potentially increasing the risk of bleeding. Specific safety data for special populations, such as pregnant or lactating women and children, are insufficient, and therefore, its use in these groups is not recommended without medical supervision. Individuals with pre-existing medical conditions or those taking other medications should consult a healthcare provider before using this supplement to avoid potential adverse effects or interactions.

Dosage

Currently, there is no standardized dosing regimen for *Scutellaria baicalensis* extract established from robust clinical trials. Preclinical studies have utilized a wide range of doses, making direct translation to human dosing challenging. Commercially available human supplements typically provide dosages ranging from 200 mg to 500 mg of extract, often standardized to a specific content of baicalin or other flavonoids. The optimal dosage for achieving therapeutic effects in humans requires further clinical validation through well-designed studies. Factors such as the timing of administration and the specific formulation (e.g., liposomal or nanoparticle delivery systems) may influence the extract's bioavailability and efficacy. Upper limits and safety thresholds for long-term human consumption have not been definitively established, underscoring the need for caution and professional guidance.

FAQs

Is it safe to take Scutellaria baicalensis long-term?

Limited human data exist on long-term safety. Preclinical studies suggest a good safety profile, but long-term human safety and efficacy are unconfirmed and require further research.

How quickly do benefits appear?

In animal models, effects have been observed within days to weeks. However, the timeline for benefits in humans is currently unknown due to limited clinical trials.

Can it replace antidepressants or cancer therapy?

No, *Scutellaria baicalensis* is not a substitute for prescribed antidepressants or conventional cancer treatments. It may offer adjunctive potential, but always consult a healthcare professional for primary treatment.

Are there known drug interactions?

Potential interactions exist with blood-thinning medications due to the flavonoid content. Always consult your healthcare provider before combining it with other drugs.

Research Sources

  • https://pmc.ncbi.nlm.nih.gov/articles/PMC10987764/ – This systematic review and meta-analysis of 13 preclinical animal studies (n=270) demonstrated significant antidepressant-like effects of *S. baicalensis*. The study highlighted its mechanisms involving inflammatory, oxidative stress, and neurotrophic pathways, providing strong preclinical evidence for its potential in depression.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC10795786/ – This meta-analysis of 12 preclinical studies on hepatocellular carcinoma (HCC) models showed that *S. baicalensis* and its flavonoids significantly reduced tumor weight and induced cell cycle arrest. The findings provide robust statistical evidence for its anticancer potential in preclinical settings.
  • https://www.mdpi.com/2076-3921/14/3/364 – This review summarized evidence on *S. baicalensis* extract-induced exosomes and their role in reducing reactive oxygen species (ROS) and inflammation. It supports the mechanistic plausibility of the extract's anti-inflammatory effects, though clinical evidence remains limited.
  • https://www.e-jar.org/journal/view.html?volume=40&number=1&spage=35 – This source (likely a review or study) contributes to the understanding of *S. baicalensis*'s anti-inflammatory and analgesic effects, potentially through the suppression of reactive oxygen species and modulation of lipid metabolism, as referenced in the benefits section.
  • https://www.mdpi.com/1467-3045/47/3/181 – This source (likely a review) discusses the therapeutic potential of baicalin and baicalein in breast cancer and other inflammatory conditions, highlighting their promise despite the current scarcity of clinical data.

Supplements Containing Scutellaria Baicalensis Extract

Xtra Concentrate by Univera
68

Xtra Concentrate

Univera

Score: 68/100
Bupleurum Dragonbone Oyster Shell Teapills by Plum Flower
83

Bupleurum Dragonbone Oyster Shell Teapills

Plum Flower

Score: 83/100
Ledebouriella Sagely Unblocks Teapills by Plum Flower
63

Ledebouriella Sagely Unblocks Teapills

Plum Flower

Score: 63/100
Long Dan Xie Gan Wan by Min Shan
65

Long Dan Xie Gan Wan

Min Shan

Score: 65/100
Pinellia Root Teapills by Min Shan
60

Pinellia Root Teapills

Min Shan

Score: 60/100
Xiao Chai Hu Wan by Min Shan
78

Xiao Chai Hu Wan

Min Shan

Score: 78/100
Clear Mountain Air Teapills by Plum Flower
70

Clear Mountain Air Teapills

Plum Flower

Score: 70/100
Huang Lian Jie Du Teapills by Plum Flower
70

Huang Lian Jie Du Teapills

Plum Flower

Score: 70/100
Major Bupleurum Teapills by Plum Flower
76

Major Bupleurum Teapills

Plum Flower

Score: 76/100
Lian Qiao Bai Du Tablet by Plum Flower
70

Lian Qiao Bai Du Tablet

Plum Flower

Score: 70/100
Xiao Chai Hu Teapills by Plum Flower
73

Xiao Chai Hu Teapills

Plum Flower

Score: 73/100
The Snake Of The Dragon Teapills by Plum Flower
70

The Snake Of The Dragon Teapills

Plum Flower

Score: 70/100